Circle-seq reveals that eccDNA may be a key blood biomarker for HBV-associated liver cancer
IntroductionExtrachromosomal circular DNA (eccDNA) regulates tumor occurrence and development. Relevant eccDNA profiles have been established for various types of cancer; however, the eccDNA expression profiles in the blood of patients with hepatocellular carcinoma (HCC) and liver cirrhosis (LC) rem...
Saved in:
Main Authors: | Xiao K. Ran, Xiao F. Zhao, Zhen W. Wei, Hua Z. Pang, Yan F. Tang, Rong Liu, Tie X. Wu, Xu D. Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2024.1454153/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exogenous plasmid capture to characterize tetracycline-resistance plasmids in sprouts obtained from retail in Germany
by: Maria Stein, et al.
Published: (2025-02-01) -
Comprehensive landscape and oncogenic role of extrachromosomal circular DNA in malignant biliary strictures
by: Zhuo Cheng, et al.
Published: (2025-02-01) -
Baseline FIB‐4 May Be a Risk Factor of Recurrence After SBRT in Patients With HBV‐Related Small HCC
by: Zhan Zeng, et al.
Published: (2025-01-01) -
Leveraging AI to automate detection and quantification of extrachromosomal DNA to decode drug responses
by: Kohen Goble, et al.
Published: (2025-02-01) -
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
by: Chiao-Ling Li, et al.
Published: (2025-01-01)